Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Agilent Technologies : Announces Pricing of $850 Million of Senior Notes

03/03/2021 | 05:57pm EDT

Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $850 million. The offering is being conducted under an automatic shelf registration statement on file with the Securities and Exchange Commission. The notes will mature in March 2031 and will bear interest at an annual rate of 2.300 percent. The offering is expected to close on March 12, 2021, subject to the satisfaction of customary closing conditions.

The estimated net proceeds of the offering are expected to be approximately $841.1 million. Agilent intends to use the net proceeds from the offering to fund the redemption of its 3.20% senior notes due 2022 (the “2022 notes”), to pay down borrowings under its commercial paper program and for general corporate purposes.

Barclays Capital Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers.

Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained from:

Barclays Capital Inc.
c/o Broadridge Financial Solutions
1155 Long Island Avenue
Edgewood, NY 11717
Email: barclaysprospectus@broadridge.com
Telephone: 1-888-603-5847

Citigroup Global Markets Inc.
c/o Broadridge Financial Solutions
1155 Long Island Avenue
Edgewood, New York 11717
Email: prospectus@citi.com
Telephone: 1-800-831-9146

J.P. Morgan Securities LLC
c/o Broadridge Financial Solutions
Attn: Prospectus Department
1155 Long Island Avenue
Edgewood, NY 11717
Telephone: 1-866-803-9204

Electronic copies of the prospectus supplement and accompanying prospectus are or will be available for free by visiting EDGAR on the Securities and Exchange Commission website at www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This press release also does not constitute a notice of redemption under the indenture governing the 2022 notes.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the federal securities laws, including with respect to the closing of Agilent’s senior notes offering and the anticipated use of the net proceeds therefrom, including the redemption of its 2022 notes. Forward-looking statements are typically identified by words or phrases such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target,” “forecast,” and other words and terms of similar meaning. These statements are subject to significant risks and uncertainties, including, without limitation, risks and uncertainties related to economic, market or business conditions and satisfaction of customary closing conditions related to the public offering. No assurance can be given that the securities offering discussed above will be consummated on the terms described or at all. Except as required by law, Agilent expressly disclaims any obligation to publicly revise any forward-looking statements contained in this news release to reflect the occurrence of events after the date of this news release.

© Business Wire 2021
04/16AGILENT TECHNOLOGIES  : Insider Sale at Agilent Technologies (A) Continues Selli..
04/15INSIDER TRENDS : Agilent Technologies Insider Continues 90-Day Selling Trend
04/15AGILENT TECHNOLOGIES  : Completes Acquisition of Resolution Bioscience, Expands ..
04/15AGILENT TECHNOLOGIES  : Named One of Singapore's Best Employers
04/13AGILENT TECHNOLOGIES  : Insider Sale at Agilent Technologies (A) Continues Selli..
04/13AGILENT TECHNOLOGIES  : Named One of Singapore's Best Employers
04/12INSIDER TRENDS : Agilent Technologies Insider Continues 90-Day Selling Trend
04/05AGILENT TECHNOLOGIES, INC. : Ex-dividend day for
04/01INSIDER TRENDS : Selling By Insiders Lingers at Agilent Technologies
03/31OXFORD BIODYNAMICS  : Enters Supply, Resale Deal with Agilent Technologies
More news
Financials (USD)
Sales 2021 5 940 M - -
Net income 2021 990 M - -
Net Debt 2021 962 M - -
P/E ratio 2021 41,2x
Yield 2021 0,57%
Capitalization 41 006 M 41 006 M -
EV / Sales 2021 7,07x
EV / Sales 2022 6,75x
Nbr of Employees 16 400
Free-Float 99,9%
Duration : Period :
Agilent Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AGILENT TECHNOLOGIES, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 18
Average target price 137,99 $
Last Close Price 134,58 $
Spread / Highest target 11,5%
Spread / Average Target 2,54%
Spread / Lowest Target -29,4%
EPS Revisions
Managers and Directors
Michael R. McMullen President, Chief Executive Officer & Director
Robert W. McMahon Chief Financial Officer & Senior Vice President
Koh Boon Hwee Non-Executive Chairman
Darlene J. S. Solomon Chief Technology Officer & Senior Vice President
Heidi Kunz Fields Independent Director
Sector and Competitors